References
- Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, Li T, Margolick JB, Pawelec G, Leng SX, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205:doi:https://doi.org/10.1016/j.arr.2020.101205
- Rodríguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, Ramírez-Santana C, Costanzo A, Ridgway WM, Ansari AA, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020;114:102506:doi:https://doi.org/10.1016/j.jaut.2020.102506
- Indini A, Rijavec E, Ghidini M, Bareggi C, Cattaneo M, Galassi B, Gambini D, Grossi F. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients. Crit Rev Oncol Hematol. 2020;153:103059. doi:https://doi.org/10.1016/j.critrevonc.2020.103059
- World Health Organization Coronavirus Disease (COVID-19). Dashboard. https://www.who.int/emergencies/diseases/novel-coronavirus-2019., 2021.
- Fensterl V, Wetzel JL, Sen GC. Interferon-induced protein Ifit2 protects mice from infection of the peripheral nervous system by vesicular stomatitis virus. J Virol. 2014;88(18):10303–11. doi:https://doi.org/10.1128/jvi.01341-14
- Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attinà A, Leggeri C, Cinelli G, Tarsitano MG, Caparello G, Carrano E, et al. COVID-19: Is there a role for immunonutrition in obese patient?J Transl Med. 2020;18(1):415:doi:https://doi.org/10.1186/s12967-020-02594-4
- Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003;6(2):223–8. doi:https://doi.org/10.1097/00075197-200303000-00012
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904–13. doi:https://doi.org/10.1016/s1470-2045(20)30310-7
- Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416–24. doi:https://doi.org/10.1080/13685538.2020.1774748
- Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol. 2020;92(10):2067–73. doi:https://doi.org/10.1002/jmv.25972
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. doi:https://doi.org/10.1016/s1470-2045(20)30096-6
- Lee LYW, Cazier J-B, Starkey T, Briggs SEW, Arnold R, Bisht V, Booth S, Campton NA, Cheng VWT, Collins G, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–16.: doi:https://doi.org/10.1016/S1470-2045(20)30442-3
- Tang LV, Hu Y. Poor clinical outcomes for patients with cancer during the COVID-19 pandemic. Lancet Oncol. 2020;21(7):862–4. doi:https://doi.org/10.1016/s1470-2045(20)30311-9
- Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol. 2021;74(1):168–84. doi:https://doi.org/10.1016/j.jhep.2020.09.031
- Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, Younas S, Hamam SSM, Rehman A. Effective immune functions of micronutrients against SARS-CoV-2. Nutrients. 2020;12(10):2992. doi:https://doi.org/10.3390/nu1210
- BourBour F, Mirzaei Dahka S, Gholamalizadeh M, Akbari ME, Shadnoush M, et al. Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus. Arch Physiol Biochem. 2020;:1–10. doi:https://doi.org/10.1080/13813455.2020.1791188
- Zhou J, Xue Y, Liu Y, Li XK, Tong ZH, Li WQ. The effect of immunonutrition in patients with acute pancreatitis: a systematic review and meta-analysis. J Hum Nutr Diet. 2021;34(2):429–39. doi:https://doi.org/10.1111/jhn.12816
- Subramanian M, Kozower BD. Immunonutrition in the esophagectomy patient: food for thought. J Thorac Dis. 2019;11(6):2218–21. doi:https://doi.org/10.21037/jtd.2019.05.63
- Jabłońska B, Mrowiec S. The role of immunonutrition in patients undergoing pancreaticoduodenectomy. Nutrients. 2020;12(9):2547. doi:https://doi.org/10.3390/nu1209
- Mueller SA, Mayer C, Bojaxhiu B, Aeberhard C, Schuetz P, et al. Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer. J Otolaryngol Head Neck Surg. 2019;48:25. doi:https://doi.org/10.1186/s40463-019-0345-8
- Hamilton-Reeves JM, Stanley A, Bechtel MD, Yankee TM, Chalise P, Hand LK, Lee EK, Smelser W, Mirza M, Wyre H, et al. Perioperative immunonutrition modulates inflammatory response after radical cystectomy: results of a pilot randomized controlled clinical trial. J Urol. 2018;200(2):292–301.: doi:https://doi.org/10.1016/j.juro.2018.03.001
- Luo Z, Wang J, Zhang Z, Li H, Huang L, Qiao Y, Wang D, Huang J, Guo L, Liu J, et al. Efficacy of early enteral immunonutrition on immune function and clinical outcome for postoperative patients with gastrointestinal cancer. JPEN J Parenter Enteral Nutr. 2018;42(4):758–65. doi:https://doi.org/10.1177/0148607117715439
- Takagi K, Umeda Y, Yoshida R, Yagi T, Fujiwara T. Systematic review on immunonutrition in partial pancreatoduodenectomy. Langenbecks Arch Surg. 2020;405(5):585–93. doi:https://doi.org/10.1007/s00423-020-01916-w
- Derbyshire E, Delange J. COVID-19: is there a role for immunonutrition, particularly in the over 65s?BMJ Nutr Prev Health. 2020;3(1):100–5. doi:https://doi.org/10.1136/bmjnph-2020-000071
- Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–74. doi:https://doi.org/10.1038/s41577-020-0311-8
- García-Suárez J, de la Cruz J, Cedillo Á, Llamas P, Duarte R, Jiménez-Yuste V, Hernández-Rivas JÁ, Gil-Manso R, Kwon M, Sánchez-Godoy P, the Asociación Madrileña de Hematología y Hemoterapia (AMHH), et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):133.: doi:https://doi.org/10.1186/s13045-020-00970-7
- Zapatera B, Prados A, Gómez-Martínez S, Marcos A. Immunonutrition: methodology and applications. Nutr Hosp. 2015;31 Suppl 3:145–54. doi:https://doi.org/10.3305/nh.2015.31.sup3.8762
- Chang JP, Pariante CM, Su KP. Omega-3 fatty acids in the psychological and physiological resilience against COVID-19. Prostaglandins Leukot Essent Fatty Acids. 2020;161:102177 doi:https://doi.org/10.1016/j.plefa.2020.102177
- Zhand S, Saghaeian Jazi M, Mohammadi S, Tarighati Rasekhi R, Rostamian G, Kalani MR, Rostamian A, George J, Douglas MW. COVID-19: The immune responses and clinical therapy candidates. IJMS. 2020;21(15):5559. doi:https://doi.org/10.3390/ijms21155559
- Raval RR, Sharabi AB, Walker AJ, Drake CG, Sharma P. Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer. J Immunother Cancer. 2014;2:14 doi:https://doi.org/10.1186/2051-1426-2-14
- Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S33–S40. doi:https://doi.org/10.1016/j.jaci.2009.09.017
- Rogero MM, Leão MDC, Santana TM, Pimentel MVdMB, Carlini GCG, da Silveira TFF, Gonçalves RC, Castro IA. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med. 2020;156:190–9. doi:https://doi.org/10.1016/j.freeradbiomed.2020.07.005
- Prieto I, Montemuiño S, Luna J, de Torres MV, Amaya E. The role of immunonutritional support in cancer treatment: Current evidence. Clin Nutr. 2017;36(6):1457–64. doi:https://doi.org/10.1016/j.clnu.2016.11.015
- Zhou T, Su TT, Mudianto T, Wang J. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J Exp Med. 2020;217(10):e20200674. doi:https://doi.org/10.1084/jem.20200674
- Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y. COVID-19: immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther. 2020;5(1):128. doi:https://doi.org/10.1038/s41392-020-00243-2
- Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827:doi:https://doi.org/10.3389/fimmu.2020.00827
- Zhang H, Wu T. CD4 + T, CD8 + T counts and severe COVID-19: A meta-analysis. J Infect. 2020;81(3):e82–e84. doi:https://doi.org/10.1016/j.jinf.2020.06.036
- Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, Wang F-S. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020;112:102473 doi:https://doi.org/10.1016/j.jaut.2020.102473
- Jiang Y, Wei X, Guan J, Qin S, Wang Z, Lu H, Qian J, Wu L, Chen Y, Chen Y, et al. COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential. Clin Immunol. 2020;218:108516:doi:https://doi.org/10.1016/j.clim.2020.108516
- Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020;26(4):453–5. doi:https://doi.org/10.1038/s41591-020-0819-2
- Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, Debnath O, Thürmann L, Kurth F, Völker MT, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970–9. doi:https://doi.org/10.1038/s41587-020-0602-4
- Moon C. Fighting COVID-19 exhausts T cells. Nat Rev Immunol. 2020;20(5):277 doi:https://doi.org/10.1038/s41577-020-0304-7
- Zhou Y, Zhang Z, Tian J, Xiong S. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus. Ann Palliat Med. 2020;9(2):428–36. doi:https://doi.org/10.21037/apm.2020.03.26
- Rao K-S, Suryaprakash V, Senthilkumar R, Preethy S, Katoh S, Ikewaki N, Abraham SJK. Role of immune dysregulation in increased mortality among a specific subset of COVID-19 patients and immune-enhancement strategies for combatting through nutritional supplements. Front Immunol. 2020;11:1548 doi:https://doi.org/10.3389/fimmu.2020.01548
- Silverio R, Gonçalves DC, Andrade MF, Seelaender M. Coronavirus disease 2019 (COVID-19) and nutritional status: The missing link? Adv Nutr. 2021;12(3):682–92. doi:https://doi.org/10.1093/advances/nmaa125
- Turnquist C, Ryan BM, Horikawa I, Harris BT, Harris CC. Cytokine storms in cancer and COVID-19. Cancer Cell. 2020;38(5):598–601. doi:https://doi.org/10.1016/j.ccell.2020.09.019
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:https://doi.org/10.1016/s0140-6736(20)30183-5
- Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, Painter CA. COVID-19 and cancer: Current challenges and perspectives. Cancer Cell. 2020;38(5):629–46. doi:https://doi.org/10.1016/j.ccell.2020.09.018
- Bumrungpert A, Pavadhgul P, Nunthanawanich P, Sirikanchanarod A, Adulbhan A. Whey protein supplementation improves nutritional status, glutathione levels, and immune function in cancer patients: a randomized, double-blind controlled trial. J Med Food. 2018;21(6):612–6. doi:https://doi.org/10.1089/jmf.2017.4080
- Yamaguchi Y, Hihara J, Hironaka K, Ohshita A, Okita R, Okawaki M, Matsuura K, Nagamine I, Ikeda T, Ohara M, et al. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome. Oncol Rep. 2006;15(4):895–901.:
- Kvarnström A, Swartling T, Kurlberg G, Bengtson JP, Bengtsson A. Pro-inflammatory cytokine release in rectal surgery: comparison between laparoscopic and open surgical techniques. Arch Immunol Ther Exp (Warsz). 2013;61(5):407–11. doi:https://doi.org/10.1007/s00005-013-0239-9
- Maio M, Hamid O, Larkin J, Covre A, Altomonte M, Calabrò L, Vardhana SA, Robert C, Ibrahim R, Anichini A, et al. Immune checkpoint inhibitors for cancer therapy in the COVID-19 era. Clin Cancer Res. 2020;26(16):4201–5. doi:https://doi.org/10.1158/1078-0432.Ccr-20-1657
- Moujaess E, Kourie HR, Ghosn M. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence. Crit Rev Oncol Hematol. 2020;150:102972 doi:https://doi.org/10.1016/j.critrevonc.2020.102972
- Salazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ, et al. Association of delayed adjuvant chemotherapy with survival after lung cancer surgery. JAMA Oncol. 2017;3(5):610–9.: doi:https://doi.org/10.1001/jamaoncol.2016.5829
- Grass F, Behm KT, Duchalais E, Crippa J, Spears GM, Harmsen WS, Hübner M, Mathis KL, Kelley SR, Pemberton JH, et al. Impact of delay to surgery on survival in stage I-III colon cancer. Eur J Surg Oncol. 2020;46(3):455–61.: doi:https://doi.org/10.1016/j.ejso.2019.11.513
- Goel AN, Lee JT, Wang MB, Suh JD. Treatment delays in surgically managed sinonasal cancer and association with survival. Laryngoscope. 2020;130(1):2–11. doi:https://doi.org/10.1002/lary.27892
- Denduluri N, Patt DA, Wang Y, Bhor M, Li X, Favret AM, Morrow PK, Barron RL, Asmar L, Saravanan S, et al. Dose delays, dose reductions, and relative dose intensity in patients with cancer who received adjuvant or neoadjuvant chemotherapy in community oncology practices. J Natl Compr Canc Netw. 2015;13(11):1383–93.: doi:https://doi.org/10.6004/jnccn.2015.0166
- Denduluri N, Lyman GH, Wang Y, Morrow PK, Barron R, Patt D, Bhowmik D, Li X, Bhor M, Fox P, et al. Chemotherapy dose intensity and overall survival among patients with advanced breast or ovarian cancer. Clin Breast Cancer. 2018;18(5):380–6.: doi:https://doi.org/10.1016/j.clbc.2018.02.003
- Braga M, Vignali A, Gianotti L, Cestari A, Profili M, et al. Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg. 1996;162:105–12.
- Yu K, Zheng X, Wang G, Liu M, Li Y, Yu P, Yang M, Guo N, Ma X, Bu Y, et al. Immunonutrition vs standard nutrition for cancer patients: a systematic review and meta-analysis (Part 1). JPEN J Parenter Enteral Nutr. 2020;44(5):742–67. doi:https://doi.org/10.1002/jpen.1736
- Cheng Y, Zhang J, Zhang L, Wu J, Zhan Z. Enteral immunonutrition versus enteral nutrition for gastric cancer patients undergoing a total gastrectomy: a systematic review and meta-analysis. BMC Gastroenterol. 2018;18(1):11. doi:https://doi.org/10.1186/s12876-018-0741-y
- Li K, Xu Y, Hu Y, Liu Y, Chen X, Zhou Y. Effect of enteral immunonutrition on immune, inflammatory markers and nutritional status in gastric cancer patients undergoing gastrectomy: a randomized double-blinded controlled trial. J Invest Surg. 2020;33(10):950–9. doi:https://doi.org/10.1080/08941939.2019.1569736
- Gutiérrez S, Svahn SL, Johansson ME. Effects of omega-3 fatty acids on immune cells. IJMS. 2019;20(20):5028. doi:https://doi.org/10.3390/ijms20205028
- Pauls SD, Rodway LA, Winter T, Taylor CG, Zahradka P, Aukema HM. Alpha-linolenic acid enhances the phagocytic and secretory functions of alternatively activated macrophages in part via changes to the oxylipin profile. Int J Biochem Cell Biol. 2020;119:105662 doi:https://doi.org/10.1016/j.biocel.2019.105662
- Gorjão R, Verlengia R, Lima T. M d, Soriano FG, Boaventura MFC, Kanunfre CC, Peres CM, Sampaio SC, Otton R, Folador A, et al. Effect of docosahexaenoic acid-rich fish oil supplementation on human leukocyte function. Clin Nutr. 2006;25(6):923–38. doi:https://doi.org/10.1016/j.clnu.2006.03.004
- Jahani M, Noroznezhad F, Mansouri K. Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy. Biomed Pharmacother. 2018;102:594–601. doi:https://doi.org/10.1016/j.biopha.2018.02.109
- Popovic PJ, Zeh HJ, 3rd, Ochoa JB. Arginine and immunity. J Nutr. 2007;137(6 Suppl 2):1681S–6s. doi:https://doi.org/10.1093/jn/137.6.1681S
- Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, Kogadeeva M, Picotti P, Meissner F, Mann M, et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167(3):829–42.e13. doi:https://doi.org/10.1016/j.cell.2016.09.031
- Li XK, Lu QB, Chen WW, Xu W, Liu R, et al. Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci Transl Med. 2018;10(459):eaat4162. doi:https://doi.org/10.1126/scitranslmed.aat4162
- Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM, Naji A. Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts. Ann Surg. 1990;211(2):202–10. doi:https://doi.org/10.1097/00000658-199002000-00013
- Talvas J, Garrait G, Goncalves-Mendes N, Rouanet J, Vergnaud-Gauduchon J, Kwiatkowski F, Bachmann P, Bouteloup C, Bienvenu J, Vasson M-P, et al. Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. Clin Nutr. 2015;34(5):810–7. doi:https://doi.org/10.1016/j.clnu.2014.12.002
- Carver JD. Dietary nucleotides: cellular immune, intestinal and hepatic system effects. J Nutr. 1994;124(1 Suppl):144S–8s. doi:https://doi.org/10.1093/jn/124.suppl_1.144S
- Grimble GK, Westwood OM. Nucleotides as immunomodulators in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2001;4(1):57–64. doi:https://doi.org/10.1097/00075197-200101000-00011
- Suchner U, Kuhn KS, Fürst P. The scientific basis of immunonutrition. Proc Nutr Soc. 2000;59(4):553–63. doi:https://doi.org/10.1017/s0029665100000793
- Watson J. The involvement of cyclic nucleotide metabolism in the initiation of lymphocyte proliferation induced by mitogens. J Immunol. 1976;117(5 Pt 1):1656–63.
- Navarro J, Maldonado J, Narbona E, Ruiz-Bravo A, García Salmerón JL, Molina JA, Gil A. Influence of dietary nucleotides on plasma immunoglobulin levels and lymphocyte subsets of preterm infants. Biofactors. 1999;10(1):67–76. doi:https://doi.org/10.1002/biof.5520100108
- Castell LM, Bevan SJ, Calder P, Newsholme EA. The role of glutamine in the immune system and in intestinal function in catabolic states. Amino Acids. 1994;7(3):231–43. doi:https://doi.org/10.1007/bf00807699
- Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?J Nutr. 2001;131(9 Suppl):2515S–22S. discussion 2523S-4S,doi:https://doi.org/10.1093/jn/131.9.2515S
- Wasinski F, Gregnani MF, Ornellas FH, Bacurau AVN, Câmara NO, Araujo RC, Bacurau RF. Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise. Mediators Inflamm. 2014;2014:326803 doi:https://doi.org/10.1155/2014/326803
- Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. Glutamine: Metabolism and immune function, supplementation and clinical translation. Nutrients. 2018;10(11):1564. doi:https://doi.org/10.3390/nu1011
- Alverdy JA, Aoys E, Weiss-Carrington P, Burke DA. The effect of glutamine-enriched TPN on gut immune cellularity. J Surg Res. 1992;52(1):34–8. doi:https://doi.org/10.1016/0022-4804(92)90275-5
- Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sorà F, Pittiruti M, Rutella S, Cicconi S, Fiorini A, D’Onofrio G, et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica. 2003;88(2):192–200.:
- Song Q-H, Xu R-M, Zhang Q-H, Shen G-Q, Ma M, Zhao X-P, Guo Y-H, Wang Y. Glutamine supplementation and immune function during heavy load training. CP. 2015;53(05):372–6. doi:https://doi.org/10.5414/CP202227
- Xu J, Sun X, Xin Q, Cheng Y, Zhan Z, Zhang J, Wu J. Effect of immunonutrition on colorectal cancer patients undergoing surgery: a meta-analysis. Int J Colorectal Dis. 2018;33(3):273–83. doi:https://doi.org/10.1007/s00384-017-2958-6
- Liu Z, Long W, Tu M, Chen S, Huang Y, Wang S, Zhou W, Chen D, Zhou L, Wang M, et al. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J Infect. 2020;81(2):318–56. doi:https://doi.org/10.1016/j.jinf.2020.03.054
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. Jama. 2020;324(8):782–93. doi:https://doi.org/10.1001/jama.2020.12839
- Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254–66. doi:https://doi.org/10.1016/j.cca.2020.05.044
- Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?J Autoimmun. 2020;111:102452 doi:https://doi.org/10.1016/j.jaut.2020.102452
- Langlois PL, D’Aragon F, Hardy G, Manzanares W. Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Nutrition. 2019;61:84–92. doi:https://doi.org/10.1016/j.nut.2018.10.026
- Grimble RF. Immunonutrition. Curr Opin Gastroenterol. 2005;21(2):216–22. doi:https://doi.org/10.1097/01.mog.0000153360.90653.82
- Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL, et al. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut. 2018;67(11):1974–83. doi:https://doi.org/10.1136/gutjnl-2017-314968
- Zhao Y, Wang C. Effect of ω-3 polyunsaturated fatty acid-supplemented parenteral nutrition on inflammatory and immune function in postoperative patients with gastrointestinal malignancy: A meta-analysis of randomized control trials in China. Medicine (Baltimore). 2018;97(16):e0472. doi:https://doi.org/10.1097/MD.0000000000010472
- Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607–13. doi:https://doi.org/10.1016/j.jinf.2020.03.037
- de Oliveira GP, Kitoko JZ, de Souza Lima-Gomes P, Rochael NC, de Araújo CC, Lugon PN, dos Santos HL, Martins EGL, Ornellas FM, de Oliveira HD, et al. Glutamine therapy reduces inflammation and extracellular trap release in experimental acute respiratory distress syndrome of pulmonary origin. Nutrients. 2019;11(4):831.: doi:https://doi.org/10.3390/nu11040
- Cengiz M, Borku Uysal B, Ikitimur H, Ozcan E, Islamoğlu MS, Aktepe E, Yavuzer H, Yavuzer S. Effect of oral l-glutamine supplementation on Covid-19 treatment. Clin Nutr Exp. 2020;33:24–31. doi:https://doi.org/10.1016/j.yclnex.2020.07.003
- Campione E, Cosio T, Rosa L, Lanna C, Di Girolamo S, Gaziano R, Valenti P, Bianchi L. Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. IJMS. 2020;21(14):4903. doi:https://doi.org/10.3390/ijms21144903
- Zhou J, Li C, Liu X, Chiu MC, Zhao X, Wang D, Wei Y, Lee A, Zhang AJ, Chu H, et al. Infection of bat and human intestinal organoids by SARS-CoV-2. Nat Med. 2020;26(7):1077–83. doi:https://doi.org/10.1038/s41591-020-0912-6
- van der Lelie D, Taghavi S. COVID-19 and the gut microbiome: more than a gut feeling. mSystems. 2020;5(4):e00453–20. doi:https://doi.org/10.1128/mSystems.00453-20
- Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol Gastrointest Liver Physiol. 2020;319(2):G245–g252. doi:https://doi.org/10.1152/ajpgi.00148.2020
- Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766–73. doi:https://doi.org/10.14309/ajg.0000000000000620
- Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y, Li W, Wang W, Liu C, Han F, et al. Glutamine and intestinal barrier function. Amino Acids. 2015;47(10):2143–54. doi:https://doi.org/10.1007/s00726-014-1773-4
- Bushen OY, Davenport JA, Lima AB, Piscitelli SC, Uzgiris AJ, Silva TMJ, Leite R, Kosek M, Dillingham RA, Girao A, et al. Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis. 2004;38(12):1764–70.: doi:https://doi.org/10.1086/421394
- Decker-Baumann C, Buhl K, Frohmüller S, Herbay AV, Dueck M, Schlag PM. Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer. Eur J Cancer. 1999;35(2):202–7. doi:https://doi.org/10.1016/S0959-8049(98)00389-X
- Costantini L, Molinari R, Farinon B, Merendino N. Impact of omega-3 fatty acids on the gut microbiota. IJMS. 2017;18(12):2645. doi:https://doi.org/10.3390/ijms18122645
- Chen G, Ran X, Li B, Li Y, He D, Huang B, Fu S, Liu J, Wang W. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine. 2018;30:317–25. doi:https://doi.org/10.1016/j.ebiom.2018.03.030